We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$163B
AUM Growth
+$23.3B
Cap. Flow
+$13.3B
Cap. Flow %
8.13%
Top 10 Hldgs %
19.78%
Holding
7,530
New
1,692
Increased
2,343
Reduced
2,156
Closed
1,075

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.21B
2
VAR
Varian Medical Systems, Inc.
VAR
+$351M
3
RP
RealPage, Inc.
RP
+$316M
4
SHOP icon
Shopify
SHOP
+$312M
5
BA icon
Boeing
BA
+$310M

Sector Composition

Rank Sector Weight
1 Technology 8.24%
2 Healthcare 7.69%
3 Financials 5.89%
4 Consumer Discretionary 5.65%
5 Industrials 4.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XXII
7151
22nd Century Group
XXII
$2.68M
0
-$6.62M
XWEL icon
7152
XWELL
XWEL
$8.93M
-1,536
Closed -$57K
YMAB
7153
DELISTED
Y-mAbs Therapeutics
YMAB
-284,888
Closed -$8.62M
ZBH icon
7154
CALL
Zimmer Biomet
ZBH
$19.3B
-155,530
Closed -$24.2M
GTM
7155
CALL
ZoomInfo Technologies
GTM
$1.16B
-7,600
Closed -$372K
GTM
7156
PUT
ZoomInfo Technologies
GTM
$1.16B
-7,600
Closed -$372K
ZION icon
7157
CALL
Zions Bancorporation
ZION
$9.95B
-26,300
Closed -$1.45M
ZION icon
7158
PUT
Zions Bancorporation
ZION
$9.95B
-26,300
Closed -$1.45M
ZTS icon
7159
CALL
Zoetis
ZTS
$32.1B
-5,100
Closed -$803K
ZVRA icon
7160
Zevra Therapeutics
ZVRA
$705M
-212,650
Closed -$1.96M
ZYXI
7161
DELISTED
Zynex
ZYXI
-329,335
Closed -$4.57M
ASTH icon
7162
Astrana Health
ASTH
$1.95B
-13,336
Closed -$361K
NTRP icon
7163
NextTrip
NTRP
$20M
-589
Closed -$44K
SER icon
7164
Serina Therapeutics
SER
$72.9M
-527
Closed -$30K
TRAW icon
7165
Traws Pharma
TRAW
$8.15M
-7,534
Closed -$2.82M
CNR
7166
Core Natural Resources Inc
CNR
$4.72B
-41,310
Closed -$402K
ONIT
7167
Onity Group
ONIT
$301M
-12,990
Closed -$369K
QCLS
7168
Q/C Technologies Inc
QCLS
$21.1M
-14
Closed -$274K
BGM
7169
BGM Group Ltd
BGM
$5.25M
-2,772
Closed -$65K
NBIS
7170
Nebius Group N.V.
NBIS
$59.6B
-51,143
Closed -$3.28M
CCEC
7171
Capital Clean Energy Carriers
CCEC
$1.36B
-14,752
Closed -$164K
EXE
7172
Expand Energy Corp
EXE
$22.2B
-893,041
Closed -$38.7M
DWTX
7173
Dogwood Therapeutics
DWTX
$84.6M
-914
Closed -$131K
IVF
7174
INVO Fertility Inc
IVF
$2.66M
-1
Closed -$121K
IRD
7175
Opus Genetics
IRD
$337M
-12,692
Closed -$74K

Similar funds

Israel Englander's Q2 2021 Portfolio in Review

As of Q2 2021, Israel Englander held 7,530 positions worth $163B, up 17% from $140B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Israel Englander deployed $13.3B of net new capital in Q2 2021, opening 1,692 new positions and adding to 2,343 existing holdings. Its largest new stake was SiteOne Landscape Supply: 609,104 shares worth $103M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Apple, an estimated $1.21B trimmed.

  • Israel Englander's largest Q2 2021 buy was SiteOne Landscape Supply: 609,104 shares worth $103M.
  • Israel Englander added most to Linde in Q2 2021, an estimated $770M increase.
  • Israel Englander's biggest Q2 2021 reduction was Apple, cutting an estimated $1.21B.
  • Israel Englander fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $351M.
  • Israel Englander's ten largest holdings make up 20% of its $163B portfolio in Q2 2021.
  • Israel Englander opened 1,692 new positions and closed 1,075 in Q2 2021.
  • Israel Englander's portfolio value rose 17% quarter-over-quarter to $163B.

Based on Millennium Management's 13F filing for Q2 2021, filed 16 Aug 2021.